Overview of Dr. Komrokji
Dr. Rami Komrokji is a hematologist in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from University of Jordan Faculty of Medicine and has been in practice 15 years. He specializes in hematologic oncology and is experienced in hematologic oncology, namely acute myeloid leukemia, Myelodysplastic syndromes, and myeloproliferative neoplasm. He is member of NCCN MDS committee. He has authored more than 200 peer reviewed papers and lectured world wide about those diseases.
Office
12902 magnolia drive
Tampa
Tampa, FL 33612- Is this information wrong?
Education & Training
- University of RochesterFellowship, Hematology and Medical Oncology, 2001 - 2004
- St Vincent Charity Medical CenterResidency, Internal Medicine, 1999 - 2001
- Columbia Saint Luke's Medical CenterResidency, Internal Medicine, 1998 - 1999
- University of Jordan Faculty of MedicineClass of 1996
Certifications & Licensure
- FL State Medical License 2008 - 2025
- OH State Medical License 1999 - 2016
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Top publication award clinical science H Lee Moffitt Cancer Center & Research Institute, 2015
- America's Top Doctors Castle Connolly, 2012-2014
- America's Top Doctors for Cancer Castle Connolly, 2011-2013
Clinical Trials
- Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma Start of enrollment: 2003 Aug 27
- S0535, Gemtuzumab and Combination Chemotherapy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia Start of enrollment: 2007 Nov 15
- A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia Start of enrollment: 2007 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- Mutations highly specific for secondary AML are associated with poor outcomes in ELN favorable risk NPM1-mutated AML.Onyee Chan, Najla Al Ali, Hammad Tashkandi, Austin Ellis, Somedeb Ball, Justin Grenet, Caroline Hana, Yehuda Deutsch, Ling Zhang, Mohammad Hussaini, Jinming Song, Seon...> ;Blood Advances. 2024 Mar 12
- TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q).Tefferi, A., Fleti, F., Chan, O., Al Ali, N., Al-Kali, A., Begna, K., Foran, J., Badar, T., Khera, N., Shah, M., Hiwase, D., Padron, E., Sallman, D., Pardanani, A., Ar...> ;British Journal of Haematology. 2023 Dec 11
- 3 citationsImetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, ra...Platzbecker, U., Santini, V., Fenaux, P., Sekeres, M., Savona, M., Madanat, Y., Díez-Campelo, M., Valcárcel, D., Illmer, T., Jonášová, A., Bělohlávková, P., Sherman, L...> ;Lancet. 2024 Jan 20
- Join now to see all
Journal Articles
- Mutational Landscape of myelodysplastic/myeloproliferative Neoplasm – Unclassifiable (MDS/MPN-U)Aziz Nazha, Rami S Komrokji, Andrew Sochacki, Mikkael A Sekeres, Prithviraj Bose, Courtney D DiNardo, Hagop M Kantarjian, Srdan Verstovsek, Sanam Loghavi, Jaroslaw P M..., Blood
Abstracts/Posters
- Outcomes of Patients with Relapsed or Refractory Acute Myeloid Leukemia Receiving Hypomethylating Agent and VenetoclaxRami S. Komrokji, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Results of a Clinical Trial of H3B-8800, a Splicing Modulator, in Patients with Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML) or Chronic Myelomonocytic...Rami S. Komrokji, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- CPX-351 As Induction Chemotherapy Yields Similar Responses and Survival Outcomes in Younger Patients (<60 Years Old) Compared to Older Patients (_60 Years Old) with Ac...Rami S. Komrokji, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- SF3B1 Clone Size Is an Independent Determinant for Overall Survival and Response to Treatment in Patients with Myelodysplastic Syndrome61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- MPN Tumor Board: Application of Novel Agents for the Treatment of Polycythemia Vera and Myelofibrosis61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- Increased Frequency of IDH1/2 Mutations in Extramedullary Acute Myeloid Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Join now to see all
Press Mentions
- Geron (GERN) Q2 2020 Earnings Call TranscriptAugust 7th, 2020
- The Use of Molecular Testing in MDSFebruary 7th, 2020
- Diagnosis of Myelodysplastic SyndromeJanuary 29th, 2020
- Join now to see all
Committees
- Member, NCCN MDS Guidelines committee 2008 - Present
Professional Memberships
- Member
Hospital Affiliations
- H. Lee Moffitt Cancer Center and Research InstituteTampa, Florida
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
AvMed Health Open Access
BCBS Blue Card PPO
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
BCBS Kansas City Preferred-Care Blue PPO
CIGNA HMO
CIGNA Open AccessCIGNA PPO
Coventry Florida - Employer Group PPO
First Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: